Savas IN

ORCID: 0000-0001-7911-3902 · 1 paper in corpus

2025

The Future of Tumor Markers: Advancing Early Malignancy Detection Through Omics Technologies, Continuous Monitoring, and Personalized Reference Intervals.

Biomolecules ·doi:10.3390/biom15071011

Malignant diseases represent a major global health challenge and are among the leading causes of death worldwide. Accurate early diagnosis is essential for improving outcomes and combating these conditions effectively. Currently, the diagno…